Brief: CASI Pharmaceuticals Announces Fourth Quarter And Full-Year 2022 Financial Results
26/04/2023 12:10
April 26 (Reuters) - CASI Pharmaceuticals Inc CASI.O :
* CASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND
FULL-YEAR 2022
FINANCIAL RESULTS
* CASI PHARMACEUTICALS INC - REPORT $10.2 MILLION IN EVOMELA
REVENUES FOR Q4
Source text for Eikon: ID:nPn17wMmqa
Further company coverage: CASI.O
Recent news on CASI Pharmaceuticals
See all newsBrief: Casi Pharmaceuticals Reports The Receipt Of Drug Registration Certificate For Thiotepa In China
CASI Pharmaceuticals Q3 revenue drops 60%, net loss widens
Brief: CASI Pharmaceuticals Inc Reports The Expiration Of Import Drug Registration License For Folotyn® In China
Casi Pharmaceuticals Inc Expected To Post A Loss Of 47 Cents A Share: Earnings Preview
Casi Pharmaceuticals Inc Reports Results For The Quarter Ended March 31: Earnings Summary